Skip to main content Back to Top
Advertisement

2/28/2025

Pimecrolimus 1% Topical Cream

Products Affected - Description

    • Elidel topical cream, Bausch Health, 1%, 100 gram tube, NDC 00187-5102-03
    • Elidel topical cream, Bausch Health, 1%, 30 gram tube, NDC 00187-5100-01
    • Elidel topical cream, Bausch Health, 1%, 60 gram tube, NDC 00187-5101-02
    • Pimecrolimus topical cream, Glenmark, 1%, 100 gram tube, NDC 68462-0609-94
    • Pimecrolimus topical cream, Glenmark, 1%, 30 gram tube, NDC 68462-0609-35
    • Pimecrolimus topical cream, Glenmark, 1%, 60 gram tube, NDC 68462-0609-65
    • Pimecrolimus topical cream, Teva, 1%, 30 gram tube, NDC 00591-2944-30
    • Pimecrolimus topical cream, Teva, 1%, 60 gram tube, NDC 00591-2944-60

Reason for the Shortage

    • Bausch Health did not provide a reason for the shortage of Elidel 1% cream. The authorized generic is available.
    • Glenmark did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.

Available Products

    • Pimecrolimus topical cream, Bausch Health, 1%, 100 gram tube, NDC 68682-0112-03
    • Pimecrolimus topical cream, Bausch Health, 1%, 30 gram tube, NDC 68682-0110-01
    • Pimecrolimus topical cream, Bausch Health, 1%, 60 gram tube, NDC 68682-0111-02
    • Pimecrolimus topical cream, Teva, 1%, 100 gram tube, NDC 00591-2944-87

Estimated Resupply Dates

    • Bausch Health has Elidel 1% topical cream in 30 gram, 60 gram, and 100 gram tubes on back order and the company cannot estimate a release date.
    • Glenmark has pimecrolimus 1% cream in 30 gram and 60 gram tubes on back order and the company estimates a release date in mid-March 2025. The 100 gram tubes are on back order and the company cannot estimate a release date.
    • Teva has pimecrolimus 1% cream in 30 gram and 60 gram tubes on intermittent back order and the company is releasing supplies as they become available.

Updated

Created February 28, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT